OGN logo

Organon & Co (OGN)

Profile

Full Name

Organon & Co.

Ticker Symbol

OGN

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United States

IPO

May 14, 2021

Indexes

Not included

Website

http://www.organon.com

Employees

10000

Key Details

Price

$11.18(-2.19%)

Market cap

$2.88B(Mid cap)

Last Dividend

$0.28

TTM Dividend yield

10.02%

Annual revenue

$6.40B(+2.24% YoY)

Annual EPS

$3.33(-16.54% YoY)

PE ratio

3.36

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$11.18
OGN price is $11.18

30-Day Relative Volume

1.18
OGN 30-day relative volume is 1.18

Price Performance

Price Most recent change

-2.19%
OGN price was down -2.19% on Apr 11, 2025

Price YTD change

-25.07%
OGN price is down -25.07% since January 1st

Price 1-year change

-38.84%
OGN price is down -38.84% year-on-year

Price 3-year change

-68.22%
OGN price is down -68.22% over the past 3 years

Price Range

Price All-time high

$39.48
OGN price is currently -71.68% below its historical high of $39.48

Price 3-year low

$10.84
OGN price is currently +3.18% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.88B
OGN market capitalization is $2.88 billion

Market cap 3-year change

-67.68%
OGN market capitalization is down -67.68% over the past 3 years

Market cap All-time high

$9.98B
OGN market capitalization is currently -71.10% below its historical high of $9.98 billion

Market cap sector rank

86.44%
OGN market capitalization is higher than 86.44% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.3%
OGN shares outstanding is up +0.3% year-on-year

Shares Outstanding 3-Year Change

+1.7%
OGN shares outstanding is up +1.7% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.79
OGN beta is 0.79

200-day SMA

$17.35
OGN price is currently -35.56% below its 200-day simple moving average

50-day SMA

$14.75
OGN price is currently -24.22% below its 50-day simple moving average

RSI

29.44
OGN 14-day relative strength index is 29.44

Volume

1.18
OGN 30-day relative volume is 1.18

ATR

$0.87
OGN average true range is $0.87

10-day Historical Volatility

95.10%
OGN 10-day historical volatility is 95.10%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.28
OGN last dividend was $0.28 per share, with an ex-dividend date of February 24, 2025

Next Dividend

-
OGN next dividend has not yet been announced

Dividend per share

Dividend per share

$1.12
OGN annual dividend per share is $1.12

Dividend per share Sector Rank

48.84%
OGN annual dividend per share is higher than 48.84% of companies in Healthcare sector

Dividend per share 1-Year Change

0%
OGN {parameterFullLabel} has remained unchanged year-on-year

Dividend per share 3-Year Change

+100%
OGN annual dividend per share is up +100% over the past 3 years

Dividend yield

Dividend yield

10.02%
OGN annual dividend yield is 10.02%

Dividend yield Sector Rank

92.94%
OGN annual dividend yield is higher than 92.94% of companies in Healthcare sector

Other

Payout ratio

34.38%
OGN annual payout ratio is 34.38%

Dividends paid

$297.00M
OGN annual dividends paid is $297.00 million

Free cash flow

$588.00M
OGN annual free cash flow is $588.00 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$6.40B
OGN annual revenue is $6.40 billion

Revenue Analysts estimate

$6.29B
OGN annual revenue is currently +1.85% higher than the consensus analysts' forecast

Revenue 1-year change

+2.24%
OGN annual revenue is up +2.24% year-on-year

Revenue Sector rank

92.72%
OGN annual revenue is higher than 92.72% of companies in Healthcare sector

EPS

EPS

$3.33
OGN annual earnings per share is $3.33

EPS Analysts estimate

$3.85
OGN annual earnings per share is currently -13.43% lower than the consensus analysts' forecast

EPS 1-year change

-16.54%
OGN annual earnings per share is down -16.54% year-on-year

EPS Sector rank

94.22%
OGN annual earnings per share is higher than 94.22% of companies in Healthcare sector

Profit

Gross profit

$3.71B
OGN annual gross profit is $3.71 billion

Gross margin

58.02%
OGN annual gross profit margin is 58.02%

Operating profit

$1.49B
OGN annual operating income is $1.49 billion

Operating margin

23.21%
OGN annual operating profit margin is 23.21%

Net income

$864.00M
OGN annual net profit is $864.00 million

Net margin

13.49%
OGN annual net profit margin is 13.49%

Expenses

Total expenses

$4.92B
OGN annual total expenses is $4.92 billion

Operating expenses

$2.23B
OGN annual total operating expenses is $2.23 billion

Cost of goods sold

$2.69B
OGN annual cost of goods sold is $2.69 billion

Selling, general & administrative expenses

$1.76B
OGN annual SGA is $1.76 billion

Depreciation and amortization

$277.00M
OGN annual depreciation & amortization is $277.00 million

Interest expense

$520.00M
OGN annual interest expense is $520.00 million

Income tax

-$57.00M
OGN annual income tax is -$57.00 million

EBIT & EBITDA

EBIT

$1.33B
OGN annual earnings before interest & taxes is $1.33 billion

EBITDA

$1.33B
OGN annual EBITDA is $1.33 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$13.10B
OGN annual total assets is $13.10 billion

Non current assets

$8.75B
OGN annual long term assets is $8.75 billion

Current assets

$4.35B
OGN annual total current assets is $4.35 billion

Cash and cash equivalents

$675.00M
OGN annual cash & cash equivalents is $675.00 million

Accounts receivable

$1.36B
OGN annual accounts receivable is $1.36 billion

Inventory

$1.32B
OGN annual inventory is $1.32 billion

Liabilities

Total liabilities

$12.63B
OGN annual total liabilities is $12.63 billion

Long term liabilities

$9.91B
OGN annual total long term liabilities is $9.91 billion

Current liabilities

$2.72B
OGN annual total current liabilities is $2.72 billion

Accounts payable

$1.15B
OGN annual accounts payable is $1.15 billion

Debt

Total debt

$8.88B
OGN annual total debt is $8.88 billion

Total debt 1-year change

+1.37%
OGN annual total debt is up +1.37% year-on-year

Long term debt

$8.86B
OGN annual long term debt is $8.86 billion

Short term debt

$20.00M
OGN annual short term debt is $20.00 million

Equity & Capital

Shareholders equity

$472.00M
OGN annual stockholders equity is $472.00 million

Book value

$472.00M
OGN annual book value is $472.00 million

Retained earnings

$1.01B
OGN annual retained earnings is $1.01 billion

Working capital

$1.63B
OGN annual working capital is $1.63 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$939.00M
OGN annual cash flow from operations is $939.00 million

Cash from operations 1-year change

+17.52%
OGN annual cash flow from operations is up +17.52% year-on-year

Cash from investing

-$513.00M
OGN annual cash flow from investing activities is -$513.00 million

Cash from investing 1-year change

-97.31%
OGN annual cash flow from investing activities is down -97.31% year-on-year

Cash from financing

-$368.00M
OGN annual cash flow from financing activities is -$368.00 million

Cash from financing 1-year change

+35.33%
OGN annual cash flow from financing activities is up +35.33% year-on-year

CAPEX

CAPEX

$351.00M
OGN annual capital expenditures is $351.00 million

CAPEX 1-year change

+34.48%
OGN annual capital expenditures is up +34.48% year-on-year

Free Cash Flow

Free cash flow

$588.00M
OGN annual free cash flow is $588.00 million

Free cash flow 1-year change

+9.29%
OGN annual free cash flow is up +9.29% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

58.02%
OGN annual gross profit margin is 58.02%

Operating margin

23.21%
OGN annual operating profit margin is 23.21%

Net margin

13.49%
OGN annual net profit margin is 13.49%

ROA & ROE

ROA

6.87%
OGN annual return on assets is 6.87%

ROE

429.85%
OGN annual return on equity is 429.85%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

3.36
OGN price to earnings ratio is 3.36

PE ratio Sector rank

5.39%
OGN price to earnings ratio is higher than 5.39% of companies in Healthcare sector

PB Ratio

PB ratio

6.11
OGN price to book ratio is 6.11

PB ratio Sector rank

86.35%
OGN price to book ratio is higher than 86.35% of companies in Healthcare sector

PS Ratio

PS ratio

0.45
OGN price to sales ratio is 0.45

PS ratio Sector rank

15.9%
OGN price to sales ratio is higher than 15.9% of companies in Healthcare sector

Enterprise value

Enterprise value

$11.09B
OGN enterprise value is $11.09 billion

Enterprise value Sector rank

92.83%
OGN enterprise value is higher than 92.83% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

7.26
OGN EV/EBITDA is 7.26

EV/EBITDA Sector rank

80.03%
OGN EV/EBITDA is higher than 80.03% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.60
OGN annual current ratio is 1.60

Quick ratio

1.11
OGN annual quick ratio is 1.11

Leverage

Debt to equity

18.81
OGN annual debt to equity ratio is 18.81

Interest coverage ratio

2.55
OGN annual interest coverage ratio is 2.55

Risk & Stability

Piotroski F-Score

5
OGN piotroski f-score is 5

Altman Z-Score

1.22
OGN altman z-score is 1.22

Analyst ratings

Recent major analysts updates

Apr 9, 25 Morgan Stanley
Equal-Weight
Feb 14, 25 Morgan Stanley
Equal-Weight
Feb 14, 25 Barclays
Overweight
Sep 6, 24 JP Morgan
Underweight
May 6, 24 Goldman Sachs
Neutral
May 3, 24 Goldman Sachs
Neutral
Apr 29, 24 Piper Sandler
Overweight
Feb 20, 24 Goldman Sachs
Neutral
Nov 22, 23 Piper Sandler
Overweight
Nov 3, 23 Goldman Sachs
Neutral

Institutional Ownership

Similar stocks

MRUS logo
Merus NV (MRUS)
PRVA logo
Privia Health (PRVA)
PRCT logo
PROCEPT BioRobotics (PRCT)
AKRO logo
Akero Therapeutics (AKRO)
SHC logo
Sotera Health (SHC)
BTSG logo
BrightSpring Health Services (BTSG)
AMED logo
Amedisys (AMED)
HAE logo
Haemonetics (HAE)
PDCO logo
Patterson Companies (PDCO)
  • What is the ticker symbol for Organon & Co?
  • Does Organon & Co pay dividends?
  • What sector is Organon & Co in?
  • What industry is Organon & Co in?
  • What country is Organon & Co based in?
  • When did Organon & Co go public?
  • Is Organon & Co in the S&P 500?
  • Is Organon & Co in the NASDAQ 100?
  • Is Organon & Co in the Dow Jones?
  • When was Organon & Co's last earnings report?
  • When does Organon & Co report earnings?
  • Should I buy Organon & Co stock now?

What is the ticker symbol for Organon & Co?

The ticker symbol for Organon & Co is NYSE:OGN

Does Organon & Co pay dividends?

Yes, Organon & Co pays dividends. The last payment was $0.28, with an ex-dividend date on February 24, 2025

What sector is Organon & Co in?

Organon & Co is in the Healthcare sector

What industry is Organon & Co in?

Organon & Co is in the Drug Manufacturers - General industry

What country is Organon & Co based in?

Organon & Co is headquartered in United States

When did Organon & Co go public?

Organon & Co's initial public offering (IPO) was on May 14, 2021

Is Organon & Co in the S&P 500?

No, Organon & Co is not included in the S&P 500 index

Is Organon & Co in the NASDAQ 100?

No, Organon & Co is not included in the NASDAQ 100 index

Is Organon & Co in the Dow Jones?

No, Organon & Co is not included in the Dow Jones index

When was Organon & Co's last earnings report?

Organon & Co's most recent earnings report was on Feb 13, 2025

When does Organon & Co report earnings?

The next expected earnings date for Organon & Co is May 2, 2025

Should I buy Organon & Co stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page